Sign In
Buy BNTC
$11.71
-0.150 (-1.26%)
At Close: Jul 31, 2026
Why Is Conagra Brands Dropping By More Than 8%? 43 Stocks Moving In Thursday's Mid-Day Session
04:00pm, Thursday, 14'th Jul 2022 Benzinga
Gainers
Shineco, Inc. (NASDAQ: SISI) shares climbed 24.5% to $1.2201 on heavy volume.
Biomerica, Inc. (NASDAQ: BMRA) gained 23.6% to $3.6599 following news the company's breast self exam will now be
Accolade Shares Jump Around 29%, Here's 75 Biggest Movers From Friday
08:35am, Tuesday, 05'th Jul 2022 Benzinga
Gainers
Omeros Corporation (NASDAQ: OMER) jumped 68.7% to close at $4.64.
Clovis Oncology, Inc. (NASDAQ: CLVS) gained 58.3% to settle at $2.85 on Friday.
Fast Radius, Inc. (NASDAQ: FSRD) jumped 41.2
Why Is Ceragon Networks Surging By 19%? 41 Stocks Moving In Tuesday's Mid-Day Session
04:17pm, Tuesday, 28'th Jun 2022 Benzinga
Gainers
Agile Therapeutics, Inc. (NASDAQ: AGRX) jumped 88.9% to $2.3986. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade.
Kezar Life Sciences, Inc.
Why Is Kezar Life Sciences Surging By 78%? 25 Stocks Moving In Tuesday's Pre-Market Session
11:00am, Tuesday, 28'th Jun 2022 Benzinga
Gainers
Kezar Life Sciences, Inc. (NASDAQ: KZR) rose 78% to $10.29 in pre-market trading after the company reported positive topline results from the MISSION Phase 2 clinical trial evaluating zetomi
This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday
08:23am, Tuesday, 28'th Jun 2022 Benzinga
Gainers
Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade.
Acutus Medical, Inc. (NASDAQ: AFIB) climbed 87.6% to cl
Zendesk, Quotient, + 40 Stocks Moving In Friday's Mid-Day Session
04:07pm, Friday, 24'th Jun 2022 Benzinga
Gainers
USA Truck, Inc. (NASDAQ: USAK) shares jumped 111% to $30.76. DB Schenker and USA Truck announced plans to combine and create premier North American transportation solutions provider.
ToughBu
Penny Stocks To Buy Now? 4 Biotech Stocks To Watch Before July 2022
03:21pm, Friday, 24'th Jun 2022 PennyStocks
Biotech penny stocks to watch right now.
The post Penny Stocks To Buy Now? 4 Biotech Stocks To Watch Before July 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.c
Penny Stocks To Buy Now? 4 Biotech Stocks To Watch Before July 2022
11:21am, Friday, 24'th Jun 2022
Biotech penny stocks to watch right now. The post Penny Stocks To Buy Now?
Benitec Biopharma Releases Q3 2022 Financial Results
12:15pm, Monday, 16'th May 2022 GlobeNewswire Inc.
HAYWARD, Calif., May 16, 2022 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “the Company”), a development-stage, gene therapy-focused, biotechnology company develop
Benzinga's Top Ratings Upgrades, Downgrades For February 17, 2022
03:02pm, Thursday, 17'th Feb 2022 Benzinga
Upgrades
HSBC upgraded the previous rating for Equinor ASA (NYSE:EQNR) from Hold to Buy. For the fourth quarter, Equinor had an EPS of $1.35, compared to year-ago quarter EPS of $0.17. The current sto
Steven Michael Oliveira Buys 10,553 Shares of Benitec Biopharma Inc. (NASDAQ:BNTC) Stock
01:30pm, Sunday, 12'th Dec 2021 Transcript Daily
Benitec Biopharma Inc. (NASDAQ:BNTC) major shareholder Steven Michael Oliveira acquired 10,553 shares of Benitec Biopharma stock in a transaction that occurred on Thursday, December 9th. The stock was bought at an average price of $3.04 per share, for a total transaction of $32,081.12. The transaction was disclosed in a document filed with the Securities & []
Benitec Biopharma to present at H.C. Wainwright's 23rd Annual Global Investment Conference
03:58pm, Monday, 13'th Sep 2021
HAYWARD, Calif., Sept. 13, 2021 /PRNewswire/ -- Benitec Biopharma, Inc. (NASDAQ: BNTC), a development-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on the
Benitec Biopharma Provides Overview of the BB-301 Phase 1b/2a Clinical Trial Design for 2022
08:10am, Wednesday, 08'th Sep 2021
HAYWARD, Calif., Sept. 8, 2021 /PRNewswire/ -- Benitec Biopharma Inc. (NASDAQ: BNTC), a development-stage biotechnology company focused on the advancement of novel genetic medicines, today provided an
Benitec Biopharma Provides Positive Updates on the BB-301 Pilot Dosing Study in Large Animals
08:05am, Wednesday, 08'th Sep 2021
HAYWARD, Calif., Sept. 8, 2021 /PRNewswire/ -- Benitec Biopharma Inc. (NASDAQ: BNTC), a development-stage biotechnology company focused on the advancement of novel genetic medicines, today provided a
Benitec Biopharma Increases Previously Announced Bought Deal Offering of Common Stock to $12.9 Million
09:55pm, Tuesday, 27'th Apr 2021
HAYWARD, Calif., April 27, 2021 /PRNewswire/ -- Benitec Biopharma Inc. (NASDAQ: BNTC) ("Benitec" or "the Company"), a development-stage, gene therapy-focused, biotechnology company developing novel g
